학술논문
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study
Document Type
Article
Author
Source
In ESMO Open June 2022 7(3)
Subject
Language
ISSN
2059-7029